Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma

Min Cheng Su, Chun Ting Chen, Fang I. Huang, Yu Ling Chen, Yung Ming Jeng, Chiao Ying Lin

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background/Purpose: Lymphoid-enhancing factor 1 (LEF1) is a transcription factor mediating Wnt/β-catenin signaling. In this study, we analyzed the clinicopathologic significance of LEF1 expression in oral squamous cell carcinoma (OSCC). Methods: Expression levels of LEF1 in 135 cases of OSCC were determined by immunohistochemistry. The results were correlated with clinicopathologic parameters and patient outcome. Results: LEF1 was only occasionally detected in basal and parabasal cells of nontumorous squamous epithelium. Overexpression of LEF1 was observed in 33 of 135 OSCCs (24%). LEF1 was more frequently expressed in moderately to poorly differentiated cancer (. p=0.0035) and was associated with lymphovascular invasion (. p=0.0252). Overexpression of LEF1 was significantly associated with poor prognosis (. p=0.0176, hazard ratio=1.96, 95% CI=1.02-3.75). Multivariate analysis revealed LEF1expression and margin status to be the significant independent predictors for overall survival. Conclusion: Our study suggests LEF1 expression in OSCC may play an important role in tumor progression and can be served as a predictor of poor prognosis for patients with OSCC.

Original languageEnglish
Pages (from-to)934-939
Number of pages6
JournalJournal of the Formosan Medical Association
Volume113
Issue number12
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

Squamous Cell Carcinoma
Catenins
Neoplasms
Transcription Factors
Multivariate Analysis
Epithelium
Epithelial Cells
Immunohistochemistry
Survival

Keywords

  • Immunohistochemistry
  • LEF1
  • Oral squamous cell carcinoma
  • Prognosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma. / Su, Min Cheng; Chen, Chun Ting; Huang, Fang I.; Chen, Yu Ling; Jeng, Yung Ming; Lin, Chiao Ying.

In: Journal of the Formosan Medical Association, Vol. 113, No. 12, 01.12.2014, p. 934-939.

Research output: Contribution to journalArticle

Su, Min Cheng ; Chen, Chun Ting ; Huang, Fang I. ; Chen, Yu Ling ; Jeng, Yung Ming ; Lin, Chiao Ying. / Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma. In: Journal of the Formosan Medical Association. 2014 ; Vol. 113, No. 12. pp. 934-939.
@article{6e4505aa442949d0963a27d9e644080d,
title = "Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma",
abstract = "Background/Purpose: Lymphoid-enhancing factor 1 (LEF1) is a transcription factor mediating Wnt/β-catenin signaling. In this study, we analyzed the clinicopathologic significance of LEF1 expression in oral squamous cell carcinoma (OSCC). Methods: Expression levels of LEF1 in 135 cases of OSCC were determined by immunohistochemistry. The results were correlated with clinicopathologic parameters and patient outcome. Results: LEF1 was only occasionally detected in basal and parabasal cells of nontumorous squamous epithelium. Overexpression of LEF1 was observed in 33 of 135 OSCCs (24{\%}). LEF1 was more frequently expressed in moderately to poorly differentiated cancer (. p=0.0035) and was associated with lymphovascular invasion (. p=0.0252). Overexpression of LEF1 was significantly associated with poor prognosis (. p=0.0176, hazard ratio=1.96, 95{\%} CI=1.02-3.75). Multivariate analysis revealed LEF1expression and margin status to be the significant independent predictors for overall survival. Conclusion: Our study suggests LEF1 expression in OSCC may play an important role in tumor progression and can be served as a predictor of poor prognosis for patients with OSCC.",
keywords = "Immunohistochemistry, LEF1, Oral squamous cell carcinoma, Prognosis",
author = "Su, {Min Cheng} and Chen, {Chun Ting} and Huang, {Fang I.} and Chen, {Yu Ling} and Jeng, {Yung Ming} and Lin, {Chiao Ying}",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.jfma.2013.07.012",
language = "English",
volume = "113",
pages = "934--939",
journal = "Journal of the Formosan Medical Association",
issn = "0929-6646",
publisher = "Elsevier Science Publishers B.V.",
number = "12",

}

TY - JOUR

T1 - Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma

AU - Su, Min Cheng

AU - Chen, Chun Ting

AU - Huang, Fang I.

AU - Chen, Yu Ling

AU - Jeng, Yung Ming

AU - Lin, Chiao Ying

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background/Purpose: Lymphoid-enhancing factor 1 (LEF1) is a transcription factor mediating Wnt/β-catenin signaling. In this study, we analyzed the clinicopathologic significance of LEF1 expression in oral squamous cell carcinoma (OSCC). Methods: Expression levels of LEF1 in 135 cases of OSCC were determined by immunohistochemistry. The results were correlated with clinicopathologic parameters and patient outcome. Results: LEF1 was only occasionally detected in basal and parabasal cells of nontumorous squamous epithelium. Overexpression of LEF1 was observed in 33 of 135 OSCCs (24%). LEF1 was more frequently expressed in moderately to poorly differentiated cancer (. p=0.0035) and was associated with lymphovascular invasion (. p=0.0252). Overexpression of LEF1 was significantly associated with poor prognosis (. p=0.0176, hazard ratio=1.96, 95% CI=1.02-3.75). Multivariate analysis revealed LEF1expression and margin status to be the significant independent predictors for overall survival. Conclusion: Our study suggests LEF1 expression in OSCC may play an important role in tumor progression and can be served as a predictor of poor prognosis for patients with OSCC.

AB - Background/Purpose: Lymphoid-enhancing factor 1 (LEF1) is a transcription factor mediating Wnt/β-catenin signaling. In this study, we analyzed the clinicopathologic significance of LEF1 expression in oral squamous cell carcinoma (OSCC). Methods: Expression levels of LEF1 in 135 cases of OSCC were determined by immunohistochemistry. The results were correlated with clinicopathologic parameters and patient outcome. Results: LEF1 was only occasionally detected in basal and parabasal cells of nontumorous squamous epithelium. Overexpression of LEF1 was observed in 33 of 135 OSCCs (24%). LEF1 was more frequently expressed in moderately to poorly differentiated cancer (. p=0.0035) and was associated with lymphovascular invasion (. p=0.0252). Overexpression of LEF1 was significantly associated with poor prognosis (. p=0.0176, hazard ratio=1.96, 95% CI=1.02-3.75). Multivariate analysis revealed LEF1expression and margin status to be the significant independent predictors for overall survival. Conclusion: Our study suggests LEF1 expression in OSCC may play an important role in tumor progression and can be served as a predictor of poor prognosis for patients with OSCC.

KW - Immunohistochemistry

KW - LEF1

KW - Oral squamous cell carcinoma

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84918782904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918782904&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2013.07.012

DO - 10.1016/j.jfma.2013.07.012

M3 - Article

C2 - 24021930

AN - SCOPUS:84918782904

VL - 113

SP - 934

EP - 939

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

SN - 0929-6646

IS - 12

ER -